MILLER RICHARD A MD — SEC Form 4 filings

SEC reporting owner CIK 1031847. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-20.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-05-07 to 2026-05-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Corvus Pharmaceuticals, Inc. (CRVS)President and CEO, Director63 legs · 584,566 sh · $1,083,4536

Form 4 filings — MILLER RICHARD A MD

FiledFormIssuerReported transactionsSource
2026-05-204Corvus Pharmaceuticals, Inc. (CRVS)Purchase (P): 5,000 @ $12.05 · Purchase (P): 1,932 @ $12.01EDGAR
2025-12-084Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 1,000,000 (derivative) @ $0EDGAR
2025-05-094Corvus Pharmaceuticals, Inc. (CRVS)Option exercise (M): 559,073 @ $3.50 · Option exercise (M): 559,073 (derivative)EDGAR
2024-12-234Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 750,000 (derivative) @ $0EDGAR
2024-05-144Corvus Pharmaceuticals, Inc. (CRVS)Gift (G): 302,016 @ $0EDGAR
2024-05-074Corvus Pharmaceuticals, Inc. (CRVS)Purchase (P): 577,634 @ $1.73 · Purchase (P): 559,073 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1031847 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →